CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

NUVAXOVID

RegulatoryapprovedNUVAXOVIDPositive
AI Analysis

Summary

NUVAXOVID, a COVID-19 vaccine by Novavax, is approved for active immunization in individuals aged 12 and older. The article provides regulatory indication information for the vaccine.

Outcome Details

NUVAXOVID approved for individuals 65 years and older, and 12-64 years of age

Importance:3/10
Sentiment:
0.50
COVID-19vaccineFDA approvalimmunization
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 27, 2026 10:06 PM

Read Original